Voss Capital’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$167M Buy
11,441,874
+1,766,874
+18% +$23.4M 7.76% 3
2026
Q1
$133M Buy
9,675,000
+1,625,000
+20% +$24.5M 7.07% 2
2025
Q4
$145M Buy
8,050,000
+1,275,000
+19% +$22.9M 6.96% 4
2025
Q3
$126M Buy
6,775,000
+1,625,000
+32% +$25.5M 6.19% 3
2025
Q2
$82.4M Buy
5,150,000
+1,306,398
+34% +$23.3M 5.68% 8
2025
Q1
$74.7M Buy
3,843,602
+603,602
+19% +$12.7M 5.73% 9
2024
Q4
$71.4M Buy
3,240,000
+39,700
+1% +$764K 5.31% 7
2024
Q3
$53.9M Buy
3,200,300
+664,414
+26% +$9.86M 4.48% 8
2024
Q2
$30.3M Buy
2,535,886
+235,886
+10% +$2.64M 3.03% 12
2024
Q1
$25.5M Buy
2,300,000
+465,000
+25% +$4.75M 2.11% 18
2023
Q4
$15.9M Buy
1,835,000
+1,238,580
+208% +$9.63M 1.55% 18
2023
Q3
$4.56M Buy
596,420
+251,285
+73% +$1.89M 0.57% 26
2023
Q2
$2.48M Buy
+345,135
New +$2.01M 0.3% 37

Other funds holding CLBT

Voss Capital's CLBT Position: Q2 2026 in Review

Voss Capital increased its Cellebrite (CLBT) stake by 18% in Q2 2026, buying an estimated $23.4M and bringing the position to 11,441,874 shares worth $167M. The position accounts for 7.76% of the portfolio, ranked #3.

Voss Capital first reported a position in CLBT in Q2 2023 and has held it in 13 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Voss Capital held 11,441,874 shares of Cellebrite worth $167M as of Q2 2026.
  • Voss Capital bought 1,766,874 Cellebrite shares in Q2 2026, an estimated $23.4M.
  • Cellebrite made up 7.76% of Voss Capital's portfolio in Q2 2026, its #3 holding.
  • Voss Capital first reported a position in Cellebrite in Q2 2023 and has held it in 13 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Voss Capital's 13F filing for Q2 2026, filed 14 Aug 2026.